We next showed that in vivo spinal intrathecal injection of AZ889 produced dose-dependent analgesia in CCI rats.
Application of AZ889 to the exposed spinal cord inhibited evoked neuronal activity and confirmed that CCR2-mediated analgesia involved predominantly the spinal cord.